全文获取类型
收费全文 | 368893篇 |
免费 | 24610篇 |
国内免费 | 8308篇 |
专业分类
耳鼻咽喉 | 4148篇 |
儿科学 | 9684篇 |
妇产科学 | 6685篇 |
基础医学 | 29692篇 |
口腔科学 | 8342篇 |
临床医学 | 40379篇 |
内科学 | 44909篇 |
皮肤病学 | 4711篇 |
神经病学 | 20146篇 |
特种医学 | 9180篇 |
外国民族医学 | 32篇 |
外科学 | 43038篇 |
综合类 | 55966篇 |
现状与发展 | 13篇 |
一般理论 | 33篇 |
预防医学 | 37687篇 |
眼科学 | 5576篇 |
药学 | 32393篇 |
443篇 | |
中国医学 | 34842篇 |
肿瘤学 | 13912篇 |
出版年
2024年 | 1178篇 |
2023年 | 6136篇 |
2022年 | 10980篇 |
2021年 | 14854篇 |
2020年 | 13857篇 |
2019年 | 19345篇 |
2018年 | 17028篇 |
2017年 | 14095篇 |
2016年 | 11298篇 |
2015年 | 10540篇 |
2014年 | 21895篇 |
2013年 | 23155篇 |
2012年 | 19668篇 |
2011年 | 21890篇 |
2010年 | 17896篇 |
2009年 | 15900篇 |
2008年 | 15343篇 |
2007年 | 15879篇 |
2006年 | 13908篇 |
2005年 | 11937篇 |
2004年 | 9655篇 |
2003年 | 8498篇 |
2002年 | 6649篇 |
2001年 | 5910篇 |
2000年 | 4880篇 |
1999年 | 4249篇 |
1998年 | 3439篇 |
1997年 | 3272篇 |
1996年 | 2830篇 |
1995年 | 2704篇 |
1994年 | 2600篇 |
1993年 | 2058篇 |
1992年 | 2106篇 |
1991年 | 1810篇 |
1990年 | 1615篇 |
1989年 | 1432篇 |
1988年 | 1355篇 |
1985年 | 3861篇 |
1984年 | 4888篇 |
1983年 | 3415篇 |
1982年 | 3889篇 |
1981年 | 3623篇 |
1980年 | 3228篇 |
1979年 | 2963篇 |
1978年 | 2599篇 |
1977年 | 1955篇 |
1976年 | 2198篇 |
1975年 | 1663篇 |
1974年 | 1451篇 |
1973年 | 1292篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
13.
徐华 《世界科学技术-中医药现代化》2022,24(5):338-348
目的 采用液质联用技术分析白鲜皮中的主要化学成分;基于网络药理学技术研究白鲜皮治疗皮肤湿疹的活性成分、作用靶点及作用机制。方法 利用液质联用技术(LC-MS)对白鲜皮主要成分进行分析,通过质谱数据结合文献资料,对各主要成分进行快速识别;通过利用SwissADME数据库对白鲜皮潜在活性成分进行预测,筛选主要作用靶点。进行KEGG通路富集分析,最终得到白鲜皮成分-靶点-疾病-通路网络图。采用分子对接技术对主要成分和作用靶点进行验证。结果 从白鲜皮中共分析鉴定了12种成分,进一步筛选得到4种潜在活性成分,可作用于48个关键靶点和14条主要通路。结论 采用LC-MS技术结合网络药理学方法,可以快速分析白鲜皮的潜在活性成分,并初步揭示了成分-靶点-通路之间的关系。通过分子对接技术可以做作用靶点进行验证。 相似文献
14.
15.
Abd-Allah H. El Ashmawy Kathleen Dowson Ahmed El-Bakoury Hazem A.H. Hosny Rathan Yarlagadda Jonathan Keenan 《The Journal of arthroplasty》2021,36(3):816-822.e1
BackgroundTotal hip and knee arthroplasties are increasingly performed operations, and routine follow-up places huge demands on orthopedic services. This study investigates the effectiveness, patients’ satisfaction, and cost reduction of Virtual Joint Replacement Clinic (VJRC) follow-up of total hip arthroplasty and total knee arthroplasty patients in a university hospital. VJRC is especially valuable when in-person appointments are not advised or feasible such as during the COVID-19 pandemic.MethodsA total of 1749 patients who were invited for VJRC follow-up for knee or hip arthroplasty from January 2017 to December 2018 were included in this retrospective study. Patients were referred to VJRC after their 6-week postoperative review. Routine VJRC postoperative review was undertaken at 1 and 7 years and then 3-yearly thereafter. We evaluated the VJRC patient response rate, acceptability, and outcome. Patient satisfaction was measured in a subgroup of patients using a satisfaction survey. VJRC costs were calculated compared to face-to-face follow-up.ResultsThe VJRC had a 92.05% overall response rate. Only 7.22% required further in-person appointments with only 3% being reviewed by an orthopedic consultant. VJRC resulted in an estimated saving of £42,644 per year at our institution. The patients’ satisfaction survey showed that 89.29% of the patients were either satisfied or very satisfied with VJRC follow-up.ConclusionVJRC follow-up for hip and knee arthroplasty patients is an effective alternative to in-person clinic assessment which is accepted by patients, has high patient satisfaction, and can reduce the cost to both health services and patients. 相似文献
16.
《Journal of vascular and interventional radiology : JVIR》2021,32(10):1449-1456
PurposeTo investigate the safety and efficacy of thyroid artery embolization (TAE) in the treatment of nodular goiter (NG).MethodsDuring a 5.5-year period, 56 consecutive patients with a NG underwent TAE. In Group A, there were 20 patients with a solitary/dominant 5–11-cm nodule, and in Group B, there were 36 patients with numerous nodules. Of the 56 patients, 47 (84%) had a retrosternal goiter and 25 had hyperthyroidism. In all patients, clinical and radiological evaluations were made at baseline and 6 months after TAE, and these parameters were statistically compared.ResultsIn 56 patients, 145 of the 146 thyroid arteries were successfully embolized. The 30-day mortality rate was 1.8%. Minor and major complications occurred in 25 and 2 patients, respectively. Six months after the TAE, the mean nodule volume was reduced from 80.2 mL to 25.0 mL, the mean thyroid volume was reduced from 147.0 mL to 62.6 mL, and the mean intrathoracic extension was reduced from 31.7 mm to 15.9 mm (P < .001). Of the 22 patients with non–Graves hyperthyroidism, 19 (86%) became euthyroid. The mean thyroid-related patient-reported outcome scores improved from 155.4 to 70.4 (P < .001). Of the 51 patients, 50 (98%) declared that they would recommend TAE to other patients with NG.ConclusionsTAE is safe and effective for the treatment of NG, with a significant volume reduction of the nodule(s) and thyroid gland. 相似文献
17.
18.
《Annales médico-psychologiques》2021,179(8):744-747
The teaching and clinical practice of professor Yves Pélicier contributed to the international development of a psychiatry centered on the whole of the person in a humanist approach. The theoretical developments were marked by the authenticity of the practice of the therapist and its deep sense of the human being thus truly founding a School. 相似文献
19.
《Journal of vascular and interventional radiology : JVIR》2022,33(4):359-367.e8
PurposeTo review and to compare indirectly the outcomes of minimally invasive therapies for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.Materials and MethodsA literature search via Medline and Cochrane Central databases was completed for randomized control studies published between January 2000 to April 2020 for the following therapies: Rezum, Urolift, Aquablation, and prostatic artery embolization (PAE). Data on the following variables were included: International prostate symptom score (IPSS), maximum urinary flow rate, quality of life, and postvoid residual (PVR). Standard mean differences between treatments were compared through a meta-analysis using transurethral resection of the prostate (TURP) to assess differences in treatment effect.ResultsThere was no significant difference in outcomes between therapies for IPSS at the 3, 6, and 12-month follow ups. Although outcomes for Rezum were only available out to 3 months, there were no consistently significant differences in outcomes when comparing Aquablation versus PAE versus Rezum. TURP PVR was significantly better than Urolift at 3, 6, and 12 months. No significant differences in minor or major adverse events were noted.ConclusionAlthough significant differences in outcomes were limited, Aquablation and PAE were the most durable at 12 months. PAE has been well studied on multiple randomized control trials with minimal adverse events while Aquablation has limited high quality data and has been associated with bleeding-related complications. 相似文献
20.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion. 相似文献